Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 5693-5703

  Saikali, Philippe ^a,b,d   Antel, Jack P ^b   Pittet, Camille L ^a   Newcombe, Jia ^c   Arbour, Nathalie ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROLASE; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 1BETA; MYELIN; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; ASTROCYTE; BRAIN TISSUE; CD8+ T LYMPHOCYTE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE FUNCTION; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WHITE MATTER;

ASTROCYTES; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL SEPARATION; COCULTURE TECHNIQUES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650650984     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002188     Document Type: Article

References (79)

1. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23:683-747.
2. Noseworthy, J. H., C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker. 2000. Multiple sclerosis. N. Engl. J. Med. 343:938-952.
3. Friese, M. A., and L. Fugger. 2005. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 128:1747-1763.
4. Zozulya, A. L., and H. Wiendl. 2008. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum. Immunol. 69:797-804.
5. Hauser, S. L., A. K. Bhan, F. Gilles, M. Kemp, C. Kerr, and H. L. Weiner. 1986. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19:578-587.
6. Neumann, H., I. M. Medana, J. Bauer, and H. Lassmann. 2002. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25:313-319.
7. Lassmann, H. 2004. Recent neuropathological findings in MS-implications for diagnosis and therapy. J. Neurol. 251 (Suppl 4): IV2-IV5.
8. Gay, F. W., T. J. Drye, G. W. Dick, and M. M. Esiri. 1997. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 120:1461-1483.
9. Babbe, H., A. Roers, A. Waisman, H. Lassmann, N. Goebels, R. Hohlfeld, M. Friese, R. Schröder, M. Deckert, S. Schmidt, et al. 2000. Clonal expansions of CD8 (+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393-404.
10. Jacobsen, M., S. Cepok, E. Quak, M. Happel, R. Gaber, A. Ziegler, S. Schock, W. H. Oertel, N. Sommer, and B. Hemmer. 2002. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125:538-550.
11. Skulina, C., S. Schmidt, K. Dornmair, H. Babbe, A. Roers, K. Rajewsky, H. Wekerle, R. Hohlfeld, and N. Goebels. 2004. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 101:2428-2433.
12. Rus, H., C. A. Pardo, L. Hu, E. Darrah, C. Cudrici, T. Niculescu, F. Niculescu, K. M. Mullen, R. Allie, L. Guo, et al. 2005. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc. Natl. Acad. Sci. USA 102:11094-11099.
13. Huseby, E. S., D. Liggitt, T. Brabb, B. Schnabel, C. Ohlén, and J. Goverman. 2001. A pathogenic role for myelin-specific CD8 (+) T cells in a model for multiple sclerosis. J. Exp. Med. 194:669-676.
14. Sun, D., J. N. Whitaker, Z. Huang, D. Liu, C. Coleclough, H. Wekerle, and C. S. Raine. 2001. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166:7579-7587.
15. Saxena, A., J. Bauer, T. Scheikl, J. Zappulla, M. Audebert, S. Desbois, A. Waisman, H. Lassmann, R. S. Liblau, and L. T. Mars. 2008. Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181:1617-1621.
16. Zehntner, S. P., M. Brisebois, E. Tran, T. Owens, and S. Fournier. 2003. Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease. FASEB J. 17:1910-1912.
17. Na, S. Y., Y. Cao, C. Toben, L. Nitschke, C. Stadelmann, R. Gold, A. Schimpl, and T. H Ünig. 2008. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 131:2353-2365.
18. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24:657-679.
19. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6:595-601.
20. Neely, G. G., S. M. Robbins, E. K. Amankwah, S. Epelman, H. Wong, J. C. Spurrell, K. K. Jandu, W. Zhu, D. K. Fogg, C. B. Brown, and C. H. Mody. 2001. Lipopolysaccharide-stimulated or granulocyte-macrophage colony-stimulating factor-stimulated monocytes rapidly express biologically active IL-15 on their cell surface independent of new protein synthesis. J. Immunol. 167:5011-5017.
21. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W. A. Muller, L. Moretta, and C. Münz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101:16606-16611.
22. Budagian, V., E. Bulanova, R. Paus, and S. Bulfone-Paus. 2006. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17:259-280.
23. Dubois, S., J. Mariner, T. A. Waldmann, and Y. Tagaya. 2002. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17:537-547.
24. Stonier, S. W., and K. S. Schluns. 2010. Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol. Lett. 127:85-92.
25. Fehniger, T. A., and M. A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood 97:14-32.
26. McInnes, I. B., B. P. Leung, R. D. Sturrock, M. Field, and F. Y. Liew. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat. Med. 3:189-195.
27. Mention, J. J., M. Ben Ahmed, B. Bègue, U. Barbe, V. Verkarre, V. Asnafi, J. F. Colombel, P. H. Cugnenc, F. M. Ruemmele, E. McIntyre, et al. 2003. In-terleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125:730-745.
28. Sakai, T., K. Kusugami, H. Nishimura, T. Ando, T. Yamaguchi, M. Ohsuga, K. Ina, A. Enomoto, Y. Kimura, and Y. Yoshikai. 1998. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 114:1237-1243.
29. Pashenkov, M., M. Mustafa, P. Kivisäkk, and H. Link. 1999. Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis. Scand. J. Immunol. 50:302-308.
30. Blanco-Jerez, C., J. F. Plaza, J. Masjuan, L. M. Orensanz, and J. C. Alvarez-Cermeño. 2002. Increased levels of IL-15 mRNA in relapsing-remitting multiple sclerosis attacks. J. Neuroimmunol. 128:90-94.
31. Kivisäkk, P., D. Matusevicius, B. He, M. Söderström, S. Fredrikson, and H. Link. 1998. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin. Exp. Immunol. 111:193-197.
32. Vaknin-Dembinsky, A., S. D. Brass, S. Brass, R. Gandhi, and H. L. Weiner. 2008. Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. [Published erratum appears in 2009 J. Neuroimmunol. 207:122.]
33. J. Neuro-immunol. 195:135-139.
34. Hanisch, U. K., S. A. Lyons, M. Prinz, C. Nolte, J. R. Weber, H. Kettenmann, and F. Kirchhoff. 1997. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J. Biol. Chem. 272:28853-28860.
35. Kurowska, M., W. Rudnicka, D. Maślińska, and W. Maślíski. 2002. Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain. Ann. N. Y. Acad. Sci. 966:441-445.
36. Lee, Y. B., J. Satoh, D. G. Walker, and S. U. Kim. 1996. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport 7:1062-1066.
37. Gómez-Nicola, D., B. Valle-Argos, M. Suardíaz, J. S. Taylor, and M. Nieto-Sampedro. 2008. Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration. J. Neuro-chem. 107:1741-1752.
38. McInnes, I. B., and J. A. Gracie. 2004. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr. Opin. Pharmacol. 4:392-397.
39. Gómez-Nicola, D., B. Valle-Argos, D. W. Pita-Thomas, and M. Nieto-Sampedro. 2008. Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Glia 56:494-505.
40. Nair, A., T. J. Frederick, and S. D. Miller. 2008. Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65:2702-2720.
41. Saikali, P., J. P. Antel, J. Newcombe, Z. Chen, M. Freedman, M. Blain, R. Cayrol, A. Prat, J. A. Hall, and N. Arbour. 2007. NKG2D-mediated cyto-toxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J. Neurosci. 27:1220-1228.
42. Jack, C. S., N. Arbour, J. Manusow, V. Montgrain, M. Blain, E. McCrea, A. Shapiro, and J. P. Antel. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175:4320-4330.
43. Arbour, N., R. Lapointe, P. Saikali, E. McCrea, T. Regen, and J. P. Antel. 2006. A new clinically relevant approach to expand myelin specific T cells. J. Immunol. Methods 310:53-61.
44. Krutzik, S. R., M. Hewison, P. T. Liu, J. A. Robles, S. Stenger, J. S. Adams, and R. L. Modlin. 2008. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181:7115-7120.
45. Schlaepfer, E., and R. F. Speck. 2008. Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering. PLoS One 3: e1999.
46. Correia, M. P., E. M. Cardoso, C. F. Pereira, R. Neves, M. Uhrberg, and F. A. Arosa. 2009. Hepatocytes and IL-15: a favorable microenvironment for T cell survival and CD8+ T cell differentiation. J. Immunol. 182:6149-6159.
47. Rubio, V., T. B. Stuge, N. Singh, M. R. Betts, J. S. Weber, M. Roederer, and P. P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9:1377-1382.
48. Suni, M. A., V. C. Maino, and H. T. Maecker. 2005. Ex vivo analysis of T-cell function. Curr. Opin. Immunol. 17:434-440.
49. Li, H., M. L. Cuzner, and J. Newcombe. 1996. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 22:207-215.
50. Jack, C. S., N. Arbour, M. Blain, U. C. Meier, A. Prat, and J. P. Antel. 2007. Th1 polarization of CD4+ T cells by Toll-like receptor 3-activated human microglia. J. Neuropathol. Exp. Neurol. 66:848-859.
51. Kohrt, H. E., C. T. Shu, T. B. Stuge, S. P. Holmes, J. Weber, and P. P. Lee. 2005. Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses. J. Immunother. 28:297-305.
52. Waldmann, T. A., and Y. Tagaya. 1999. The multifaceted regulation of in-terleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17:19-49.
53. Jana, M., J. A. Anderson, R. N. Saha, X. Liu, and K. Pahan. 2005. Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes. Free Radic. Biol. Med. 38:655-664.
54. Williams, A., G. Piaton, and C. Lubetzki. 2007. Astrocytes-friends or foes in multiple sclerosis? Glia 55:1300-1312.
55. Basu, A., J. K. Krady, and S. W. Levison. 2004. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78:151-156.
56. Probert, L., and K. Selmaj. 1997. TNF and related molecules: trends in neuro-science and clinical applications. J. Neuroimmunol. 72:113-117.
57. Owens, T. 2002. Identification of new therapeutic targets for prevention of CNS inflammation. Expert Opin. Ther. Targets 6:203-215.
58. Benveniste, E. N. 1998. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9:259-275.
59. Brilot, F., T. Strowig, S. M. Roberts, F. Arrey, and C. Münz. 2007. NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J. Clin. Invest. 117:3316-3329.
60. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of in-terleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest. 96:2578-2582.
61. Dubsky, P., H. Saito, M. Leogier, C. Dantin, J. E. Connolly, J. Banchereau, and A. K. Palucka. 2007. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Eur. J. Immunol. 37:1678-1690.
62. Miranda-Carús, M. E., A. Balsa, M. Benito-Miguel, C. Pérez de Ayala, and E. Martín-Mola. 2004. IL-15 and the initiation of cell contact-dependent syno-vial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of meth-otrexate. J. Immunol. 173:1463-1476.
63. Oppenheimer-Marks, N., R. I. Brezinschek, M. Mohamadzadeh, R. Vita, and P. E. Lipsky. 1998. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J. Clin. Invest. 101:1261-1272.
64. Ferrari-Lacraz, S., E. Zanelli, M. Neuberg, E. Donskoy, Y. S. Kim, X. X. Zheng, W. W. Hancock, W. Maslinski, X. C. Li, T. B. Strom, and T. Moll. 2004. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J. Immunol. 173:5818-5826.
65. Villadsen, L. S., J. Schuurman, F. Beurskens, T. N. Dam, F. Dagnaes-Hansen, L. Skov, J. Rygaard, M. M. Voorhorst-Ogink, A. F. Gerritsen, M. A. van Dijk, et al. 2003. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J. Clin. Invest. 112:1571-1580.
66. Chong, M. M., Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. Kay, and H. E. Thomas. 2004. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. J. Immunol. 172:5714-5721.
67. Demirci, G., T. B. Strom, and X. C. Li. 2003. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and-independent mechanisms. J. Immunol. 171:3878-3885.
68. Gomez-Nicola, D., A. Spagnolo, C. Guaza, and M. Nieto-Sampedro. 2010. Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice. Exp. Neurol. 222:235-242.
69. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-780.
70. van Loo, G., R. De Lorenzi, H. Schmidt, M. Huth, A. Mildner, M. Schmidt-Supprian, H. Lassmann, M. R. Prinz, and M. Pasparakis. 2006. Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7:954-961.
71. Brambilla, R., T. Persaud, X. Hu, S. Karmally, V. I. Shestopalov, G. Dvoriantchikova, D. Ivanov, L. Nathanson, S. R. Barnum, and J. R. Bethea. 2009. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182:2628-2640.
72. Petrovas, C., Y. M. Mueller, I. D. Dimitriou, P. M. Bojczuk, K. C. Mounzer, J. Witek, J. D. Altman, and P. D. Katsikis. 2004. HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J. Immunol. 172:4444-4453.
73. Huntington, N. D., H. Puthalakath, P. Gunn, E. Naik, E. M. Michalak, M. J. Smyth, H. Tabarias, M. A. Degli-Esposti, G. Dewson, S. N. Willis, et al. 2007. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat. Immunol. 8:856-863.
74. Perera, L. P., C. K. Goldman, and T. A. Waldmann. 1999. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 162:2606-2612.
75. McInnes, I. B., J. al-Mughales, M. Field, B. P. Leung, F. P. Huang, R. Dixon, R. D. Sturrock, P. C. Wilkinson, and F. Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:175-182.
76. Hüe, S., J. J. Mention, R. C. Monteiro, S. Zhang, C. Cellier, J. Schmitz, V. Verkarre, N. Fodil, S. Bahram, N. Cerf-Bensussan, and S. Caillat-Zucman. 2004. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21:367-377.
77. Jabri, B., and L. M. Sollid. 2006. Mechanisms of disease: immunopathogenesis of celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 3:516-525.
78. Meresse, B., Z. Chen, C. Ciszewski, M. Tretiakova, G. Bhagat, T. N. Krausz, D. H. Raulet, L. L. Lanier, V. Groh, T. Spies, et al. 2004. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21:357-366.
79. Meresse, B., S. A. Curran, C. Ciszewski, G. Orbelyan, M. Setty, G. Bhagat, L. Lee, M. Tretiakova, C. Semrad, E. Kistner, et al. 2006. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203:1343-1355.